BE730510A - - Google Patents

Info

Publication number
BE730510A
BE730510A BE730510DA BE730510A BE 730510 A BE730510 A BE 730510A BE 730510D A BE730510D A BE 730510DA BE 730510 A BE730510 A BE 730510A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE730510A publication Critical patent/BE730510A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/041,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE730510D 1968-03-26 1969-03-26 BE730510A (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770061 DE1770061A1 (de) 1968-03-26 1968-03-26 Neue substituierte 3-Amino-4-bromsydnomimine

Publications (1)

Publication Number Publication Date
BE730510A true BE730510A (https=) 1969-09-26

Family

ID=5700383

Family Applications (1)

Application Number Title Priority Date Filing Date
BE730510D BE730510A (https=) 1968-03-26 1969-03-26

Country Status (18)

Country Link
AT (1) AT285619B (https=)
BE (1) BE730510A (https=)
BG (1) BG15220A3 (https=)
BR (1) BR6907417D0 (https=)
CA (1) CA945990A (https=)
CH (1) CH519511A (https=)
DE (1) DE1770061A1 (https=)
DK (1) DK130296B (https=)
ES (2) ES364979A1 (https=)
FI (1) FI54480C (https=)
FR (1) FR2004770A1 (https=)
GB (1) GB1219254A (https=)
HU (1) HU162735B (https=)
IE (1) IE32708B1 (https=)
IL (1) IL31909A (https=)
NL (1) NL6904632A (https=)
SE (1) SE374746B (https=)
YU (1) YU69369A (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
HU162735B (https=) 1973-04-28
FR2004770A1 (https=) 1969-11-28
AT285619B (de) 1970-11-10
IE32708L (en) 1969-09-26
YU69369A (en) 1978-09-18
GB1219254A (en) 1971-01-13
IE32708B1 (en) 1973-10-31
IL31909A (en) 1973-01-30
BG15220A3 (bg) 1975-11-21
IL31909A0 (en) 1969-05-28
FI54480B (fi) 1978-08-31
SE374746B (https=) 1975-03-17
ES376981A1 (es) 1972-05-01
DK130296C (https=) 1975-06-30
NL6904632A (https=) 1969-09-30
ES364979A1 (es) 1971-02-16
FI54480C (fi) 1978-12-11
DK130296B (da) 1975-02-03
CA945990A (en) 1974-04-23
DE1770061A1 (de) 1971-09-16
BR6907417D0 (pt) 1973-04-12
CH519511A (de) 1972-02-29

Similar Documents

Publication Publication Date Title
AU5506869A (https=)
AU5184069A (https=)
AU6168869A (https=)
AU6171569A (https=)
AU2952567A (https=)
DK130296C (https=)
AU4811568A (https=)
AU4744468A (https=)
BE709435A (https=)
AU3083868A (https=)
BE726357A (https=)
BE727134A (https=)
BE723306A (https=)
BE727197A (https=)
BE716533A (https=)
BE712305A (https=)
BE709496A (https=)
BE709484A (https=)
BE709479A (https=)
BE709446A (https=)
BE708888A (https=)
BE709415A (https=)
BE709320A (https=)
BE709319A (https=)
BE709301A (https=)